Developer docs
API playgroundTry for free, no card

Search company profiles

See-Mode Technologies

Full company profile

uuid00027m6

Namestring
See-Mode Technologies
Legal namestring
See-Mode Technologies Pte Ltd
Websiteurl
see-mode.com
Company typeenum
Private
Founded yearint
2018
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging AI, ultrasound reporting, thyroid nodule detection, breast lesion analysis, radiology automation
Industry4 codes
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAK
Teleradiology Platforms & Reading Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1AI-Powered Ultrasound Software Licensing
TypeSubscription Recurring
Description

See-Mode generates revenue through licensing its FDA-cleared AI software for thyroid and breast ultrasound analysis to healthcare providers, imaging clinics, and teleradiology groups. The company operates as part of DeepHealth (RadNet's digital health division) following acquisition in June 2025.

see-mode.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise licensing for healthcare providers
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing tailored to healthcare provider needs, including imaging centers and hospitals.

see-mode.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

See-Mode Technologies develops FDA-cleared AI-powered software that automatically analyzes ultrasound images to detect, size, and characterize thyroid nodules (per ACR TI-RADS guidelines) and breast lesions (per ACR BI-RADS guidelines). The platform generates complete sonographer worksheets and pre-populates radiologist report templates, integrating with PACS/RIS systems and partner platforms to streamline radiology workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Up to 30% reduction in scan time
+4 more records
Product overview1 text field

See-Mode Technologies offers AI-enhanced ultrasound reporting solutions organized around two core products—Thyroid and Breast—that work within a unified Workflow platform. The Thyroid product provides automatic nodule detection and characterization according to ACR TI-RADS guidelines, while the Breast product identifies lesions and automates BI-RADS reporting. Both products integrate through the Workflow platform, which offers sonographer worksheets, radiologist viewers, and API integration for seamless connectivity with existing healthcare systems and platform partners.

Product and service3 records
1Thyroid Ultrasound AI
CategoryMedical Imaging AI - Thyroid Ultrasound
Description

AI-powered thyroid ultrasound reporting solution that automatically detects, sizes, and characterizes thyroid nodules according to ACR TI-RADS guidelines, producing complete TI-RADS sonographer worksheets and preliminary radiologist impressions. Designed for sonographers, radiologists, imaging clinics, and teleradiology groups.

2Breast Ultrasound AI
CategoryMedical Imaging AI - Breast Ultrasound
Description

AI-powered breast ultrasound reporting solution that identifies breast lesions in ultrasound imaging and automates BI-RADS reporting, including characteristics and suspicion level assessment. Reduces inter-operator variability and reporting errors for radiologists and imaging centers.

3Workflow Integration Platform
CategoryWorkflow Platform / API Integration
Description

Suite of workflow integration solutions including enhanced sonographer experience (automated reporting), streamlined radiologist experience (radiologist viewer), and API integration for outpatient clinics and teleradiology groups. Enables seamless connectivity with existing healthcare systems, PACS, RIS, and platform partner solutions.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-06-04
Description

RadNet, Inc. (NASDAQ: RDNT) acquired See-Mode Technologies in June 2025 for innovation in AI-powered ultrasound diagnostics. The acquisition integrates See-Mode's FDA-approved AI technology into DeepHealth, RadNet's digital health subsidiary. Early deployment across 12 RadNet imaging centers demonstrated up to 30% reduction in scan time. The technology is being integrated across RadNet's network of over 900 ultrasound units.

Strategic tierCoreTypeTechnology or Integration
Description

Blackford is a platform partner offering See-Mode's AI-powered ultrasound reporting integration. Outpatient clinics can access See-Mode's automated worksheet capabilities through Blackford's radiology platform.

Strategic tierCoreTypeTechnology or Integration
Description

CARPL serves as a platform partner providing access to See-Mode's AI technology. Healthcare providers using CARPL's platform can integrate See-Mode's automated thyroid and breast ultrasound reporting capabilities.

Strategic tierCoreTypeTechnology or Integration
Description

Ferrum Health is a platform partner enabling access to See-Mode's AI-powered ultrasound reporting. The integration allows outpatient clinics to leverage See-Mode through Ferrum Health's healthcare AI platform.

Strategic tierCoreTypeTechnology or Integration
Description

Synthesis Health provides platform access to See-Mode's AI solutions. Outpatient clinics using Synthesis Health's platform can integrate See-Mode's automated worksheet capabilities for improved radiology workflows.

6Altus Medical Imaging
Strategic tierCoreTypeTechnology or Integration
Description

Altus Medical Imaging partners with See-Mode to deliver consistently high-quality thyroid ultrasounds. Radiologists at Altus use See-Mode's AI to ensure the highest level of care for patients and provide accurate, reliable results for referrers.

see-mode.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Arterys (now part of Tempus) provides cloud-native AI medical imaging platform for radiology workflows, including ultrasound and MRI interpretation. It is comparable as an AI imaging software vendor targeting radiology workflows with cloud-based deployment models.

TypeBroad incumbent
Description

GE HealthCare's Edison AI platform and ultrasound division offer embedded AI features for radiology reporting and workflow. As a broad incumbent with a massive installed base of ultrasound machines, GE HealthCare represents both a competitor and a potential distribution partner for AI ultrasound automation.

TypeOthers
Description

Blackford is both a See-Mode platform partner and an AI imaging marketplace operator. It is comparable as an enabler/distributor that integrates third-party AI imaging algorithms (including See-Mode's) into clinical workflows for radiology customers.

TypeBroad incumbent
Description

Hologic is a major women's health medical device company whose mammography and breast ultrasound systems increasingly embed AI-driven reporting capabilities. As a broad incumbent, Hologic competes with See-Mode at the imaging-suite level rather than as a standalone AI software vendor.

TypeOthers
Description

Ferrum Health is a healthcare AI platform that curates and deploys third-party AI algorithms, including See-Mode's. It is comparable as a distribution and integration partner that exposes See-Mode's capabilities to a broader hospital and clinic customer base.

TypeDirect peer
Description

Volpara develops AI software for breast imaging, including automated breast density assessment and mammography reporting. It is the most direct competitor to See-Mode's breast ultrasound BI-RADS automation, targeting the same radiology customer base with overlapping AI-driven reporting workflows.

TypeDirect peer
Description

Lunit develops AI for medical imaging, including Lunit INSIGHT for mammography and Lunit SCOPE for biomarker analysis. It is a direct competitor in AI-augmented radiology reporting with FDA-cleared products targeting breast cancer detection in a comparable customer base of imaging clinics and hospitals.

TypeBroad incumbent
Description

Philips offers ultrasound systems with AI-augmented reporting features and an enterprise imaging portfolio. As a broad incumbent in medical imaging, Philips competes for AI workflow integration budgets and could bundle similar capabilities into its ultrasound installed base.

TypeOthers
Description

DeepHealth is RadNet's digital health subsidiary and now See-Mode's parent company. It is comparable as the integrating platform for population-scale AI imaging deployment and serves as the corporate vehicle through which See-Mode's technology reaches end users.

TypeDirect peer
Description

iCAD provides AI-powered breast cancer detection and risk assessment solutions (ProFound AI), primarily for mammography with extensions to DBT and breast ultrasound. It directly competes in breast imaging AI reporting and shares the same clinical guidelines (BI-RADS) integration approach as See-Mode.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

See-Mode Technologies

Medical Imaging AI Softwaresee-mode.com

See-Mode Technologies firmographics

Firmographics
Name
See-Mode Technologies
Legal name
See-Mode Technologies Pte Ltd
Website
https://see-mode.com
Company type
Private
Founded year
2018
Operating status
Acquired
Headcount range
11–50 employees
Ownership category
akta.pro rank

See-Mode Technologies industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHDAAAEAH
Medical Imaging AI
SECONDARYHLACALAJ
Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHLACALAK
Teleradiology Platforms & Reading Workflow
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT

Keywords

  • Medical imaging AI
  • Ultrasound reporting
  • Thyroid nodule detection
  • Breast lesion analysis
  • Radiology automation

Where See-Mode Technologies is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

See-Mode Technologies business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. AI-Powered Ultrasound Software Licensing: See-Mode generates revenue through licensing its FDA-cleared AI software for thyroid and breast ultrasound analysis to healthcare providers, imaging clinics, and teleradiology groups. The company operates as part of DeepHealth (RadNet's digital health division) following acquisition in June 2025.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing for healthcare providers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

See-Mode Technologies product offering

Product offering

Core offering

See-Mode Technologies develops FDA-cleared AI-powered software that automatically analyzes ultrasound images to detect, size, and characterize thyroid nodules (per ACR TI-RADS guidelines) and breast lesions (per ACR BI-RADS guidelines). The platform generates complete sonographer worksheets and pre-populates radiologist report templates, integrating with PACS/RIS systems and partner platforms to streamline radiology workflows.

Product overview

See-Mode Technologies offers AI-enhanced ultrasound reporting solutions organized around two core products—Thyroid and Breast—that work within a unified Workflow platform. The Thyroid product provides automatic nodule detection and characterization according to ACR TI-RADS guidelines, while the Breast product identifies lesions and automates BI-RADS reporting. Both products integrate through the Workflow platform, which offers sonographer worksheets, radiologist viewers, and API integration for seamless connectivity with existing healthcare systems and platform partners.

Differentiator

Problem solved

Functional benefit

Products and services

  • Thyroid Ultrasound AI AI-powered thyroid ultrasound reporting solution that automatically detects, sizes, and characterizes thyroid nodules according to ACR TI-RADS guidelines, producing complete TI-RADS sonographer worksheets and preliminary radiologist impressions. Designed for sonographers, radiologists, imaging clinics, and teleradiology groups.
  • Breast Ultrasound AI AI-powered breast ultrasound reporting solution that identifies breast lesions in ultrasound imaging and automates BI-RADS reporting, including characteristics and suspicion level assessment. Reduces inter-operator variability and reporting errors for radiologists and imaging centers.
  • Workflow Integration Platform Suite of workflow integration solutions including enhanced sonographer experience (automated reporting), streamlined radiologist experience (radiologist viewer), and API integration for outpatient clinics and teleradiology groups. Enables seamless connectivity with existing healthcare systems, PACS, RIS, and platform partner solutions.

Quantifiable outcome

  • Up to 30% reduction in scan time
  • +4 more outcomes

Companies that use See-Mode Technologies

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

See-Mode Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature9 records

See-Mode Technologies partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship and core.

  • RadNet / DeepHealthflagshipStrategic or Co-development Partner · 4 June 2025RadNet, Inc. (NASDAQ: RDNT) acquired See-Mode Technologies in June 2025 for innovation in AI-powered ultrasound diagnostics. The acquisition integrates See-Mode's FDA-approved AI technology into DeepHealth, RadNet's digital health subsidiary. Early deployment across 12 RadNet imaging centers demonstrated up to 30% reduction in scan time. The technology is being integrated across RadNet's network of over 900 ultrasound units.
  • BlackfordcoreTechnology or IntegrationBlackford is a platform partner offering See-Mode's AI-powered ultrasound reporting integration. Outpatient clinics can access See-Mode's automated worksheet capabilities through Blackford's radiology platform.
  • CARPLcoreTechnology or IntegrationCARPL serves as a platform partner providing access to See-Mode's AI technology. Healthcare providers using CARPL's platform can integrate See-Mode's automated thyroid and breast ultrasound reporting capabilities.
  • Ferrum HealthcoreTechnology or IntegrationFerrum Health is a platform partner enabling access to See-Mode's AI-powered ultrasound reporting. The integration allows outpatient clinics to leverage See-Mode through Ferrum Health's healthcare AI platform.
  • Synthesis HealthcoreTechnology or IntegrationSynthesis Health provides platform access to See-Mode's AI solutions. Outpatient clinics using Synthesis Health's platform can integrate See-Mode's automated worksheet capabilities for improved radiology workflows.
  • Altus Medical ImagingcoreTechnology or IntegrationAltus Medical Imaging partners with See-Mode to deliver consistently high-quality thyroid ultrasounds. Radiologists at Altus use See-Mode's AI to ensure the highest level of care for patients and provide accurate, reliable results for referrers.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

See-Mode Technologies competitors and assessment

Company assessment

Direct peers

  • Arterys: Arterys (now part of Tempus) provides cloud-native AI medical imaging platform for radiology workflows, including ultrasound and MRI interpretation. It is comparable as an AI imaging software vendor targeting radiology workflows with cloud-based deployment models.
  • Volpara Health: Volpara develops AI software for breast imaging, including automated breast density assessment and mammography reporting. It is the most direct competitor to See-Mode's breast ultrasound BI-RADS automation, targeting the same radiology customer base with overlapping AI-driven reporting workflows.
  • Lunit: Lunit develops AI for medical imaging, including Lunit INSIGHT for mammography and Lunit SCOPE for biomarker analysis. It is a direct competitor in AI-augmented radiology reporting with FDA-cleared products targeting breast cancer detection in a comparable customer base of imaging clinics and hospitals.
  • iCAD: iCAD provides AI-powered breast cancer detection and risk assessment solutions (ProFound AI), primarily for mammography with extensions to DBT and breast ultrasound. It directly competes in breast imaging AI reporting and shares the same clinical guidelines (BI-RADS) integration approach as See-Mode.

Broad incumbents

  • GE HealthCare: GE HealthCare's Edison AI platform and ultrasound division offer embedded AI features for radiology reporting and workflow. As a broad incumbent with a massive installed base of ultrasound machines, GE HealthCare represents both a competitor and a potential distribution partner for AI ultrasound automation.
  • Hologic: Hologic is a major women's health medical device company whose mammography and breast ultrasound systems increasingly embed AI-driven reporting capabilities. As a broad incumbent, Hologic competes with See-Mode at the imaging-suite level rather than as a standalone AI software vendor.
  • Philips (Image-Guided Therapy / Ultrasound): Philips offers ultrasound systems with AI-augmented reporting features and an enterprise imaging portfolio. As a broad incumbent in medical imaging, Philips competes for AI workflow integration budgets and could bundle similar capabilities into its ultrasound installed base.

Others

  • Blackford Analysis: Blackford is both a See-Mode platform partner and an AI imaging marketplace operator. It is comparable as an enabler/distributor that integrates third-party AI imaging algorithms (including See-Mode's) into clinical workflows for radiology customers.
  • Ferrum Health: Ferrum Health is a healthcare AI platform that curates and deploys third-party AI algorithms, including See-Mode's. It is comparable as a distribution and integration partner that exposes See-Mode's capabilities to a broader hospital and clinic customer base.
  • DeepHealth (parent): DeepHealth is RadNet's digital health subsidiary and now See-Mode's parent company. It is comparable as the integrating platform for population-scale AI imaging deployment and serves as the corporate vehicle through which See-Mode's technology reaches end users.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

See-Mode Technologies social profiles

Digital presence

See-Mode Technologies compliance and trust

Trust signal

Compliance5 records

See-Mode Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

See-Mode Technologies leadership team

Management profile

Number of profiles

Profiles2 records

See-Mode Technologies funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

See-Mode Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about See-Mode Technologies

What does See-Mode Technologies do?

See-Mode Technologies develops FDA-cleared AI-powered software that automatically analyzes ultrasound images to detect, size, and characterize thyroid nodules (per ACR TI-RADS guidelines) and breast lesions (per ACR BI-RADS guidelines). The platform generates complete sonographer worksheets and pre-populates radiologist report templates, integrating with PACS/RIS systems and partner platforms to streamline radiology workflows.

Is See-Mode Technologies a public or private company?

See-Mode Technologies is a private company. It is classified as corporate owned and is currently acquired.

When was See-Mode Technologies founded?

See-Mode Technologies was founded in 2018. It employs 11 to 50 people.

Where is See-Mode Technologies based?

See-Mode Technologies is headquartered in Melbourne, Australia, in the Oceania region.

How does See-Mode Technologies make money?

One revenue line is on record: AI-Powered Ultrasound Software Licensing.

Who are See-Mode Technologies's main competitors?

Direct peers on record are Arterys, Volpara Health, Lunit and iCAD. Broad incumbents are GE HealthCare, Hologic and Philips (Image-Guided Therapy / Ultrasound). Others are Blackford Analysis, Ferrum Health and DeepHealth (parent).

Does See-Mode Technologies have an API?

Yes. See-Mode's API enables integration with existing workflow systems, automatically populating worksheets with AI-generated findings and reducing manual data entry. The API serves outpatient clinics that have existing worksheet solutions and are leveraging a platform partner.

What industry is See-Mode Technologies in?

See-Mode Technologies's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 33451 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comBreast Ultrasound Market Overview: Major Segments, Strategic Developments, and Leading CompaniesThe breast ultrasound market is projected to reach $5.58 billion by 2030, growing at a compound annual growth rate of 12.4%, driven by AI integration, portable devices, and 3D/4D imaging advancements. In June 2025, RadNet Inc. acquired Singapore-based See-Mode Technologies to integrate AI-driven breast ultrasound technology into its DeepHealth solutions, and in March 2025, GE HealthCare launched the FDA-approved Invenia ABUS Premium system featuring AI-assisted scan quality assessment.YahooSee-Mode Technologies Receives FDA Clearance for Thyroid Ultrasound AI Analysis and Reporting SoftwareSee-Mode Technologies received FDA 510(k) clearance for its thyroid ultrasound AI analysis and reporting software. The software detects and classifies thyroid nodules using ACR TI-RADS systems, and is the first FDA-cleared product for thyroid ultrasound CADe/x. It aims to reduce reporting time and inter-operator variability.GlobeNewswireBlackford and See-Mode Partner to Bring AI Breast and Thyroid Detection Software to the Blackford PlatformBlackford and See-Mode announced a commercial partnership to integrate See-Mode's breast and thyroid detection software into Blackford's AI platform. The integration aims to reduce reporting time and increase diagnostic confidence for clinicians. See-Mode's technology automatically detects and classifies lesions in ultrasound images.NewswireClear Medical Imaging and See-Mode Technologies Announce Partnership via CureLabs Innovation HubClear Medical Imaging announced a partnership with See-Mode Technologies to adopt AI software for ultrasound reporting. The rollout will start with vascular products, followed by breast and thyroid later this year, aiming to address ultrasound technologist shortages. The partnership is implemented via CureLabs Innovation Hub.PR NewswireClear Medical Imaging and See-Mode Technologies Announce Partnership via CureLabs Innovation HubClear Medical Imaging and See-Mode Technologies announced a partnership via CureLabs to adopt See-Mode's AI software for ultrasound workflow. The rollout will start with vascular products, followed by breast and thyroid later this year, aiming to mitigate ultrasound technologist shortages. See-Mode has Health Canada regulatory approval for clinical use.PR NewswireSee-Mode Technologies Secures Regulatory Approvals for its AI-powered Software that Automatically Analyses and Reports Breast & Thyroid Ultrasound Scans in Australia and New ZealandSee-Mode Technologies received regulatory approvals for its AI-powered breast and thyroid ultrasound reporting software in Australia and New Zealand. The company's AI detects lesions and assigns BI-RADS and TI-RADS classifications, aiming to reduce unnecessary biopsies and improve diagnostic accuracy. The approvals expand its presence in the region.BioWorldFDA clears 510(k) for See-Mode Technologies’ AI software to better detect strokesSee-Mode Technologies received FDA 510(k) clearance for its Augmented Vascular Analysis (AVA) program, which uses AI to analyze vascular ultrasound scans for stroke prediction. Stroke affects about 15 million people annually and is the second-leading cause of death globally.AiThorityMedTech Startup See-Mode Technologies Receives FDA Clearance for AI Software That Automatically Analyses and Reports Vascular Ultrasound ScansSee-Mode Technologies received FDA 510(k) clearance for its AI software AVA, which automates vascular ultrasound analysis and reporting. The startup plans to bring AVA to the U.S. market within the year, and it is pending CE approval in Europe.FinSMEsSee-Mode Technologies Secures US$7M in Series A FundingSee-Mode Technologies, a Singapore-Australia MedTech startup, raised US$7M in Series A funding led by MassMutual Ventures Southeast Asia. The company will use the funds to expand into Europe and the US, double its team size, and strengthen R&D and sales. Its stroke-prediction product AVA is approved in Singapore, with CE and FDA approvals pending.The Sydney Morning HeraldStroke prediction startup See-Mode secures $9 million investmentSee-Mode, a Melbourne stroke prediction startup, secured $9 million in funding from investors including Blackbird Ventures. The company will use the capital to expand its AI-based medical imaging analysis into Europe and the United States. Its first product is already used commercially in Singapore and piloted in Australian hospitals.